Regulator of G-protein signaling 12 (RGS12)

Regulator of G-protein signaling 12 (RGS12) is a multifunctional intracellular protein encoded by the RGS12 gene and is a member of the regulator of G protein signaling (RGS) family[1][3]. RGS12 acts both as a GTPase-activating protein (GAP) for G-protein α-subunits, thereby accelerating the termination of G protein-coupled receptor (GPCR) signals, and as a transcriptional repressor in a cell cycle-dependent manner[2][3]. It is unique among RGS proteins because it contains multiple functional domains, including PDZ, phosphotyrosine-binding, Ras-binding domains, and a GoLoco motif, enabling interaction with a diverse array of signaling pathways such as MAPK, Ras, and RTKs[2][6]. RGS12 plays critical roles in skeletal muscle regeneration, osteoclast and osteoblast differentiation, and redox regulation by modulating Nrf2 proteasomal degradation[2][5][6][7]. It has been implicated in tumorigenesis, bone and muscle diseases, and inflammation, and is considered a potential therapeutic target for osteoporosis, bone disorders, and some cancers[6][7]. No direct drug interactions are currently reported; however, its complex scaffold and enzymatic functions make it an attractive candidate for future pharmacologic modulation[3][5].

Other names

Regulator of G protein signaling 12RGS12regulator of G-protein signaling 12regulator of G-protein signalling 12

GTPase-activating (inhibits G protein-coupled receptor signaling by promoting GTP hydrolysis on Gα subunits); Transcriptional repression; Scaffolding for MAPK/ERK signaling pathways; Modulation of Nrf2 proteasomal degradation (regulates redox state)